Hyperfine booth

May 9, 2022

2025 08 05 Mri Molecular Profiles Thumbnail

MRI shows promise profiling hepatocellular carcinoma tumors

August 5, 2025

Ovarian Cancer2 400

MRI-based DL model improves ovarian lesion classification

August 5, 2025

Echelon Synergy 1.5T MRI with MotionClear Comprehensive Motion Correction Suite

Echelon Synergy 1.5T MRI with MotionClear Comprehensive Motion Correction Suite

January 1, 2025

Runner Woman Adobe Izf

fMRI confirms yet again that exercise really does improve mood

July 31, 2025

MRI shows promise profiling hepatocellular carcinoma tumors

A study suggests that imaging-based screening with targeted pathological workup could help refine treatment strategies.

August 5, 2025

2025 08 05 Mri Molecular Profiles Thumbnail

MRI-based DL model improves ovarian lesion classification

By Amerigo Allegretto

A deep-learning (DL) model accurately differentiated malignant from benign ovarian lesions on MRI scans and reduced segmentation time.

August 5, 2025

Ovarian Cancer2 400

Hyperfine enrolls 100th patient in neurology study

By AuntMinnie.com staff writers

The company reached this milestone 16 weeks after the study began, it said.

August 4, 2025

fMRI confirms yet again that exercise really does improve mood

By Kate Madden Yee

The findings offer a "more nuanced neurobiological model for the therapeutic effects of exercise," the researchers noted.

July 31, 2025

Runner Woman Adobe Izf

Hyperfine highlights first patients enrolled in PRIME study

By AuntMinnie.com staff writers

Hyperfine has enrolled the first patients in a study that will evaluate the effectiveness of the Swoop portable MRI system.

July 31, 2025

Emergency Entrance 400

MRI-based model predicts treatment response in breast cancer patients

By Amerigo Allegretto

An MRI-based model performed well in predicting pathologic complete response in women with triple-negative breast cancer.

July 30, 2025

MR image from a 55-year-old patient with triple-negative breast cancer from training set. (A, above) Axial postcontrast T1-weighted image from baseline MRI exam shows unifocal enhancing mass (unifocality: positive). (B, below) Axial postcontrast T1-weighted image from MRI examination per-formed after one cycle of neoadjuvant chemoimmunotherapy shows >37% reduction in lesion size (early tumor shrinkage: positive) and development of non-enhancing region within lesion (percentage enhancement reduction: positive).

Data transparency is lacking for FDA-cleared Alzheimer's AI technology

Lack of transparency raises concerns about algorithmic bias impacting care planning for patients with Alzheimer's disease.

July 30, 2025

Amyloid Plaque Alzheimer

In-bore MRI-targeted biopsy effective in prostate cancer

Concordance between biopsy and surgical grade groups was moderate (60.2%), with a risk of undergrading, researchers reported.

July 29, 2025

Prostate Imaging

Adverse reaction rates to GBCAs are low in children

By Kate Madden Yee

The review suggests gadolinium-based contrast agents (GBCAs) are relatively safe for children.

July 29, 2025

Contrast Injector

ARRT launches imaging assistant MRI credential

By AuntMinnie.com staff writers

The credential is designed to "support, not replace, the expertise of MR technologists," the ARRT said.

July 28, 2025

MRI reveals effects of ultraprocessed food on the heart

By Kate Madden Yee

MRI shows that a higher intake of ultraprocessed food is associated with a greater burden of atherosclerotic plaque in the carotid artery.

July 28, 2025

MRI experts release MRI safety handbook

By AuntMinnie.com staff writers

A team of MRI experts has launched a safety handbook for the modality.

July 28, 2025

Page 1 of 623